GlucoTrack, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 4.44 million compared to USD 4.07 million a year ago. Basic loss per share from continuing operations was USD 0.29 compared to USD 0.26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.494 USD | -10.20% | -14.84% | +88.91% |
Apr. 22 | GlucoTrack, Inc. announced that it has received $0.5 million in funding | CI |
Apr. 16 | Glucotrack Expanding Glucose Monitoring Technology to Epidural Space | MT |
1st Jan change | Capi. | |
---|---|---|
+88.91% | 14.72M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- GCTK Stock
- News GlucoTrack, Inc.
- GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022